Oral integrity and salivary profile in myeloma patients undergoing high-dose therapy followed by autologous SCT

Bone Marrow Transplantation

Volumn 43, Issue 10, 2009, Pages 801-806

  Avivi, I ^a,b   Avraham, S ^a   Koren Michowitz, M ^c   Zuckerman, T ^a   Aviv, A ^a   Ofran, Y ^a   Benyamini, N ^a   Nagler, A ^c   Rowe, J M ^a,b   Nagler, R M ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL DERIVATIVE; IMMUNOGLOBULIN A; MELPHALAN; PEROXIDASE; SUPEROXIDE DISMUTASE; URIC ACID;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG INDICATION; DRUG MEGADOSE; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; MOUTH MUCOSA; MUCOSA INFLAMMATION; MYELOMA; PRIORITY JOURNAL; SALIVA ANALYSIS; SALIVA LEVEL; SALIVATION; TASTE DISORDER; TISSUE INJURY; XEROSTOMIA;

ADULT; AGED; ALBUMINS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN A; MALE; MELPHALAN; MIDDLE AGED; MOUTH; MUCOSITIS; MULTIPLE MYELOMA; OXIDATIVE STRESS; SALIVA; TRANSPLANTATION, AUTOLOGOUS;

EID: 67349263413     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.387     Document Type: Article

References (26)

1. Barlogie B, Shaughnessy J, Tricot G, Jacobson J, Zangari M, Anaissie E et al. Treatment of multiple myeloma. Blood 2004; 103: 20-32.
2. Attal M, Harousseau JL, Facon T, Guilhot F, Doyen C, Fuzibet JG et al. Intergroupe Francophone du Myelome. Single versus double autologous stem cell transplantation for multiple myeloma. N Engl J Med 2003; 349: 2495-2502.
3. Copelan EA. Hematopoietic stem cell transplantation. N Engl J Med 2006; 354: 1813-1826.
4. McGuire DB, Altomonte V, Peterson DE, Wingard JR, Jones RJ, Grochow LB. Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation. Oncol Nurs Forum 1993; 20: 1493-1502.
5. Sonis ST. Pathobiology of oral mucositis: Novel insights and opportunities. J Support Oncol 2007; 9 (Suppl 4): 3-11.
6. Bellm LA, Epstein JB, Rose-Pad A, Martin P, Duchs HJ. Patient reports of complications of bone marrow transplantation. Support Care Cancer 2000; 8: 33-39.
7. Garfunkel AA. Oral mucositis - the search for a solution. N Engl J Med 2006; 351: 2649-2651.
8. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J et al. Clinical practice guidelines for the prevention and treatment cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004; 100 (Suppl 9): 2026-2046.
9. Blijlevens N, Schwenkglenks M, Bacon P, D'Addio A, Einsele H, Maertens J et al. Prospective oral mucositis audit: Oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy - European Blood and Marrow transplantation mucositis advisory group. J Clin Oncol 2008; 26: 1519-1525.
10. Micozzi A, Cartoni C, Monaco M, Martino P, Zittoun R, Mandelli F. High incidence of infectious gastrointestinal complications observed in patients with acute myeloid leukemia receiving intensive chemotherapy for first induction of remission. Support Care Cancer 1996; 4 294-297.
11. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M et al. Mucositis study section of the multinational association for supportive care in cancer; International Society for Oral Oncology.Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004; 100: 1995-2025.
12. Harrison T, Bigler L, Tucci M, Pratt L, Malamud F, Thigpen JT et al. Salivary sIgA concentrations and stimulated whole saliva flow rates among women undergoing chemotherapy for breast cancer: An exploratory study. Spec Care Dentist 1998; 18: 109-112.
13. Dens F, Boogaerts M, Boute P, Declerck D, Demuynck H, Vinckier F. Quantitative determination of immunological components of salivary gland secretion in transplant recipients. Bone Marrow Transplant 1996; 17: 421-423.
14. Biron P, Sebban C, Gourmet R, Chvetzoff G, Philip I, Blay JY. Research controversies in management of oral mucositis. Support Care Cancer 2000; 8: 68-71.
15. Nagler R, Hershkovich O, Lischinsky S, Diamond E, Reznick AZ. Saliva analysis in the clinical setting: Revisiting an underused diagnostic tool. J Investig Med 2002; 50: 214-225.
16. Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2: 235-254.
17. Pruitt KM, Kamau DN, Miller K, Mansson-Rahemtulla B, Rahemtulla F. Quantitative, standardized assays for determining the concentrations of bovine lactoperoxidase, human salivary peroxidase, and human myeloperoxidase. Anal Biochem 1990; 191: 278-286.
18. Ukeda H, Maeda S, Ishii T, Sawamura M. Spectrophotometric assay for superoxide dismutase based on tetrazolium salt
19. Moreau P, Facon T, Attal M, Hulin C, Michallet M, Maloisel F et al. Intergroupe Francophone du Myélome. Comparison of 200 mg/m(2) melphalan and 8Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: Final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial. Blood 2002; 99: 731-735.
20. Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma. J Support Oncol 2007; 5: 231-235.
21. Grazziutti ML, Dong L, Miceli MH, Krishna SG, Kiwan E, Syed N et al. Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: Incidence, risk factors and a severity predictive model. Bone Marrow Transplant 2006; 38: 501-506.
22. Sonis ST. The pathobiology of mucositis. Nat Rev Cancer 2004; 4 277-284.
23. Sculley DV, Langley-Evans SC. Periodontal disease is associated with lower antioxidant capacity in whole saliva and evidence of increased protein oxidation. Clin Sci (Lond) 2003; 105: 167-172.
24. Beal MF. Oxidatively modified proteins in aging and disease. Free Radic Biol Med 2002; 32: 797-803.
25. Månsson-Rahemtulla B, Techanitiswad T, Rahemtulla F, McMillan TO, Bradley EL, Wahlin YB. Analyses of salivary components in leukemia patients receiving chemotherapy. Oral Surg Oral Med Oral Pathol 1992; 73: 35-46.
26. Epstein JB, Tsang AH, Warkentin D, Ship JA. The role of salivary function in modulating chemotherapyinduced oropharyngeal mucositis: A review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 94: 39-44.